Author

Paul Friedemann

Institutions: Max Delbrück Center, Charité - Universitätsmedizin Berlin

Observed institutions: Max Delbrück Center, Freie Universität Berlin, Charité - Universitätsmedizin Berlin

OpenAlex ID: A5091485271

Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease

2022 · Thomas Grüter, Franziska E Möllers, et al. · Brain · 124

CSF Findings in Acute NMDAR and LGI1 Antibody–Associated Autoimmune Encephalitis

2021 · Marc Dürr, Gunnar Nissen, et al. · Neurology Neuroimmunology & Neuroinflammation · 72

A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies

2022 · Christine Strippel, Marisol Herrera-Rivero, et al. · Brain · 46

Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis

2021 · Anja K. Tietz, Klemens Angstwurm, et al. · Neurology Neuroimmunology & Neuroinflammation · 35

Safety and Efficacy of Satralizumab in Patients with Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD): Results from the Phase 3 METEOROID Trial (PL5.006)

2026 · Michael Levy, Eoin Flanagan, et al. · Neurology · 3

Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis

2022 · Hadas Stiebel-Kalish*, Kerstin Rubarth, et al. · Research Square · 1

Works count: 6

Citation count: 281

H-index: 4

I10-index: 4